Scientists from Duke-NUS Medical School and the National Centre for Infectious Diseases (NCID) found that 2003 SARS survivors who have been vaccinated with the Pfizer-BioNTech mRNA vaccine produced highly potent functional antibodies that are capable of neutralizing not only all known SARS-CoV-2 variants of concerns (VOCs) but also other animal coronaviruses that have the potential to cause human infection.
The study was conducted by scientists from the Duke-NUS medical school and the National Centre for Infectious Diseases.. Read more at straitstimes.com.
Research boosts hopes for broad vaccine to combat Covid variants and future coronavirus outbreaks miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Singapore designs smart fabric as medical support for elderly biospectrumasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumasia.com Daily Mail and Mail on Sunday newspapers.